Massachusetts General Hospital

IOM honors seven

MGH Hotline 10.16.09 Seven MGH-affiliated physicians and researchers join prestigious Institute of Medicine seven MGH-affiliated physicians and researchers were among the 65 new members and five foreign associates recently elected to the prestigious Institute of Medicine (IOM), a recognized leader for independent, scientifically informed analysis and recommendations on health issues.

Walker joins American Academy of Arts and Sciences

MGH Hotline 04.23.10 Bruce Walker, MD, director of the Ragon Institute of MGH, MIT and Harvard, is among 229 individuals who have been selected to join the American Academy of Arts and Sciences (AAAS) this year.

MGH receives top honor for stroke patients’ quality of care

The MGH has received a top honor from the Massachusetts Department of Public Health (DPH) for its commitment to improving its quality of care to stroke patients.

HIV is evolving to evade human immune responses

HIV is evolving rapidly to escape the human immune system, an international study has shown. The findings demonstrate the challenge of developing an HIV vaccine that keeps pace with the changing nature of the virus.

New Institute for Tuberculosis and HIV Research Created in South Africa

A groundbreaking partnership between the Howard Hughes Medical Institute and the University of KwaZulu-Natal in South Africa will establish an international research center focused on the worldwide effort to control the devastating co-epidemic of tuberculosis and HIV.

NIH renews Harvard Center for AIDS Research grant for another five years

The National Institutes of Health has renewed for five years - and $18.1 million - the funding for the Harvard University Center for AIDS Research (Harvard CFAR). Harvard is one of only 20 NIH CFAR sites in the U.S. and first received the designation in 2004.

New insights into the mystery of natural HIV immunity

Researchers from the Ragon Institute of MGH, MIT and Harvard discover how a genetic factor increases the immune system's ability to control HIV.

Small protein changes may make big difference in natural HIV control

Tiny variants in a protein that alerts the immune system to the presence of infection may underlie the rare ability of some individuals to control HIV infection without the need for medications.

Scientists reveal HIV weakness

In a new finding that may allow vaccine designers to sidestep HIV's rapid mutation rate, researchers at the Ragon Institute of MGH, MIT and Harvard have identified sections of an HIV protein where mutations would actually undermine the virus’ fitness – its ability to survive and reproduce.

Natural HIV control may rely on sequence of T cell receptor protein

The rare ability of some individuals to control HIV infection with their immune system alone appears to depend – at least partially – on specific qualities of the immune system's killer T cells and not on how many of those cells are produced.